Clinical Trials Directory

Trials / Completed

CompletedNCT01927822

Factors Influencing the Abortion Interval of Second-trimester Termination of Pregnancy Using Misoprostol

Status
Completed
Phase
Study type
Observational
Enrollment
101 (actual)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
Female
Age
13 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Detailed description

Misoprostol is the primary drug of choice for medical termination. It is not only cheap, but also stable at room temperature and easily available worldwide. It is indicated for the treatment of gastritis, but is widely used off-label for a variety of indications in the practice of obstetrics and gynecology, including medication abortion, induction of labor, and the treatment of postpartum hemorrhage. The optimal dosage and route of administration have not been well defined and vary with physicians. The potency of misoprostol's effect varies with dosage, route of administration and dosing interval; both maternal and fetal factors may, to certain extent, affect the abortion interval. This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2013-08-23
Last updated
2015-07-07

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01927822. Inclusion in this directory is not an endorsement.